Live tape
Top 8, mentions 7d12,241SPCX2,544 mentions▲ +0.08GOOGL2,023 mentions▲ +0.02META1,926 mentions▲ +0.04TSLA1,824 mentions▲ +0.05NFLX1,027 mentions▲ +0.02QQQ1,021 mentions▲ +0.05AMZN948 mentions▲ +0.06NVDA928 mentions▲ +0.07

Equity

EXAS

Exact Sciences (EXAS)

Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for EXAS to draw a line in its place.

Exact Sciences (EXAS) insider trades

SEC Form 4

EXAS has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 23 March 2026.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
23 Mar 2026 Baranick Brian EVP, GM, Precision Oncology Award 33,321
23 Mar 2026 Baranick Brian EVP, GM, Precision Oncology Other 137,990
23 Mar 2026 Herriott James SVP, General Counsel & Sec Other 69,957
23 Mar 2026 Bloomer Aaron EVP, Chief Financial Officer Award 89,911
23 Mar 2026 Bloomer Aaron EVP, Chief Financial Officer Other 139,096
23 Mar 2026 Condella Sarah EVP, Human Resources Award 60,389
23 Mar 2026 Condella Sarah EVP, Human Resources Other 198,259
23 Mar 2026 Conroy Kevin T President and CEO Award 119,312
23 Mar 2026 Conroy Kevin T President and CEO Other 1,677,514
23 Mar 2026 ORVILLE JACOB A EVP, GM, Screening Award 53,323
23 Mar 2026 ORVILLE JACOB A EVP, GM, Screening Other 155,500
23 Mar 2026 COWARD D SCOTT Director Other 62,256

Showing the 12 most recent of 43 compensation filings in this window. The figures above count all of them.

Exact Sciences (EXAS) institutional holders (13F)

SEC Form 13F SEC EDGAR

0 of the 45 institutional funds we track reported a Exact Sciences position for the quarter ended 31 Mar 2026; the latest of those filings landed 15 May 2026.

Congressional trades in Exact Sciences (EXAS)

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in Exact Sciences is a sale by Kevin Hern (house, OK), dated 24 Mar 2026.

Date Member Type Amount
24 Mar 2026 filed 03 Apr 2026 Kevin Hern house · Republican–OK Sale $1K–$15K
10 May 2024 filed 08 Jun 2024 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
01 Feb 2024 filed 07 Mar 2024 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
02 Jan 2024 filed 11 Feb 2024 Kevin Hern house · Republican–OK Sale $1K–$15K
13 Nov 2023 filed 08 Dec 2023 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
16 Oct 2023 filed 11 Nov 2023 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K
15 Sep 2023 filed 15 Oct 2023 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
01 May 2023 filed 11 Jun 2023 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K

Exact Sciences (EXAS): frequently asked questions

From live data

Have Exact Sciences insiders bought or sold shares recently?

No Exact Sciences insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 23 Mar 2026 (SEC Form 4).

How many institutions hold Exact Sciences?

0 of the 45 institutional funds we track reported a Exact Sciences position for the quarter ended 31 Mar 2026, per SEC Form 13F filings.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

Sources

  1. TradingViewthe price chart widget, drawn by TradingView from their own data
  2. SEC EDGARSEC EDGAR 13F filings
  3. House disclosuresU.S. House of Representatives financial disclosures
  4. Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Exact_Sciences_Corporation